Literature DB >> 23610372

Direct and indirect antigen presentation lead to deletion of donor-specific T cells after in utero hematopoietic cell transplantation in mice.

Amar Nijagal1, Chris Derderian, Tom Le, Erin Jarvis, Linda Nguyen, Qizhi Tang, Tippi C Mackenzie.   

Abstract

In utero hematopoietic cell transplantation (IUHCTx) is a promising method to induce donor-specific tolerance but the mechanisms of antigen presentation that educate host T cells and the relative importance of deletion vs regulation in this setting are unknown. We studied the roles of direct and indirect antigen presentation (mediated by donor- and host-derived antigen-presenting cells [APCs], respectively) in a mouse model of IUHCTx. We found that IUHCTx leads to precocious maturation of neonatal host dendritic cells (DCs) and that there is early differentiation of donor-derived DCs, even after transplantation of a stem cell source without mature APCs. We next performed allogeneic IUHCTx into donor-specific T-cell receptor transgenic mice and confirmed that both direct and indirect antigen presentation lead to clonal deletion of effector T cells in chimeras. Deletion did not persist when chimerism was lost. Importantly, although the percentage of regulatory T cells (Tregs) after IUHCTx increased, there was no expansion in Treg numbers. In wild-type mice, there was a similar deletion of effector cells without expansion of donor-specific Tregs. Thus, tolerance induction after IUHCTx depends on both direct and indirect antigen presentation and is secondary to thymic deletion, without de novo Treg induction.

Entities:  

Mesh:

Year:  2013        PMID: 23610372      PMCID: PMC3668492          DOI: 10.1182/blood-2012-10-463174

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  37 in total

1.  Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Authors:  E J Suchin; P B Langmuir; E Palmer; M H Sayegh; A D Wells; L A Turka
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

2.  The ability of B cells and dendritic cells to present antigen increases during ontogeny.

Authors:  S Muthukkumar; J Goldstein; K E Stein
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

3.  High-level allogeneic chimerism achieved by prenatal tolerance induction and postnatal nonmyeloablative bone marrow transplantation.

Authors:  William H Peranteau; Satoshi Hayashi; Michael Hsieh; Aimen F Shaaban; Alan W Flake
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

4.  Indirect minor histocompatibility antigen presentation by allograft recipient cells in the draining lymph node leads to the activation and clonal expansion of CD4+ T cells that cause obliterative airways disease.

Authors:  David M Richards; Stacy L Dalheimer; Benjamin D Ehst; Tracy L Vanasek; Marc K Jenkins; Marshall I Hertz; Daniel L Mueller
Journal:  J Immunol       Date:  2004-03-15       Impact factor: 5.422

5.  CD4+ T-cell receptor transgenic T cells alone can reject vascularized heart transplants through the indirect pathway of alloantigen recognition.

Authors:  Kazuhito Honjo; Xiao yan Xu; R Pat Bucy
Journal:  Transplantation       Date:  2004-02-15       Impact factor: 4.939

6.  Indirect allorecognition can play an important role in the development of transplant arteriosclerosis.

Authors:  Stephan M Ensminger; Bernd M Spriewald; Oliver Witzke; Octavio E Pajaro; Magdi H Yacoub; Peter J Morris; Marlene L Rose; Kathryn J Wood
Journal:  Transplantation       Date:  2002-01-27       Impact factor: 4.939

7.  Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy.

Authors:  R S Lee; K Yamada; S L Houser; K L Womer; M E Maloney; H S Rose; M H Sayegh; J C Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

8.  Loss of direct and maintenance of indirect alloresponses in renal allograft recipients: implications for the pathogenesis of chronic allograft nephropathy.

Authors:  R J Baker; M P Hernandez-Fuentes; P A Brookes; A N Chaudhry; H T Cook; R I Lechler
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

9.  Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes.

Authors:  Satoshi Hayashi; Michael Hsieh; William H Peranteau; Shuichi Ashizuka; Alan W Flake
Journal:  Exp Hematol       Date:  2004-03       Impact factor: 3.084

10.  Mechanisms of early peripheral CD4 T-cell tolerance induction by anti-CD154 monoclonal antibody and allogeneic bone marrow transplantation: evidence for anergy and deletion but not regulatory cells.

Authors:  Josef Kurtz; Juanita Shaffer; Ariadne Lie; Natalie Anosova; Gilles Benichou; Megan Sykes
Journal:  Blood       Date:  2004-02-12       Impact factor: 22.113

View more
  24 in total

1.  Depletion of murine fetal hematopoietic stem cells with c-Kit receptor and CD47 blockade improves neonatal engraftment.

Authors:  Russell G Witt; Bowen Wang; Quoc-Hung Nguyen; Carlo Eikani; Aras N Mattis; Tippi C MacKenzie
Journal:  Blood Adv       Date:  2018-12-26

2.  Induced pluripotent stem cell-derived gamete-associated proteins incite rejection of induced pluripotent stem cells in syngeneic mice.

Authors:  Eun-Mi Kim; Gohar Manzar; Nicholas Zavazava
Journal:  Immunology       Date:  2017-03-22       Impact factor: 7.397

3.  Systemic multilineage engraftment in mice after in utero transplantation with human hematopoietic stem cells.

Authors:  Russell G Witt; Emily M Kreger; Laura B Buckman; Patriss W Moradi; Phong T Ho; S Christopher Derderian; Perry Tsai; Chris Baker; Nathaniel Schramm; Rachel Cleary; J Victor Garcia; Tippi C MacKenzie
Journal:  Blood Adv       Date:  2018-01-05

4.  Enhanced in utero allogeneic engraftment in mice after mobilizing fetal HSCs by α4β1/7 inhibition.

Authors:  Aimee G Kim; Jesse D Vrecenak; Matthew M Boelig; Linda Eissenberg; Michael P Rettig; John S Riley; Matthew S Holt; Michael A Conner; Stavros P Loukogeorgakis; Haiying Li; John F DiPersio; Alan W Flake; William H Peranteau
Journal:  Blood       Date:  2016-09-20       Impact factor: 22.113

5.  Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.

Authors:  Michela Frascoli; Cerine Jeanty; Shannon Fleck; Patriss W Moradi; Sheila Keating; Aras N Mattis; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

6.  Prenatal Allogeneic Tolerance in Mice Remains Stable Despite Potent Viral Immune Activation.

Authors:  Beverly S I Strong; Katherine O Ryken; Amanda E Lee; Lucas E Turner; Ram K Wadhwani; Tess J Newkold; Amir M Alhajjat; Jonathan W Heusel; Aimen F Shaaban
Journal:  J Immunol       Date:  2015-09-11       Impact factor: 5.422

7.  In utero depletion of fetal hematopoietic stem cells improves engraftment after neonatal transplantation in mice.

Authors:  S Christopher Derderian; P Priya Togarrati; Charmin King; Patriss W Moradi; Damien Reynaud; Agnieszka Czechowicz; Irving L Weissman; Tippi C MacKenzie
Journal:  Blood       Date:  2014-05-30       Impact factor: 22.113

8.  Regulatory T cells promote alloengraftment in a model of late-gestation in utero hematopoietic cell transplantation.

Authors:  John S Riley; Lauren E McClain; John D Stratigis; Barbara E Coons; Nicholas J Ahn; Haiying Li; Stavros P Loukogeorgakis; Camila G Fachin; Andre I B S Dias; Alan W Flake; William H Peranteau
Journal:  Blood Adv       Date:  2020-03-24

9.  Alloreactive fetal T cells promote uterine contractility in preterm labor via IFN-γ and TNF-α.

Authors:  Michela Frascoli; Lacy Coniglio; Russell Witt; Cerine Jeanty; Shannon Fleck-Derderian; Dana E Myers; Tzong-Hae Lee; Sheila Keating; Michael P Busch; Philip J Norris; Qizhi Tang; Giovanna Cruz; Lisa F Barcellos; Nardhy Gomez-Lopez; Roberto Romero; Tippi C MacKenzie
Journal:  Sci Transl Med       Date:  2018-04-25       Impact factor: 17.956

10.  Maternal and Fetal Immune Response to in Utero Stem Cell Transplantation.

Authors:  Amir Alhajjat; Aimen Shaaban
Journal:  Curr Stem Cell Rep       Date:  2018-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.